MOTTA, ILARIA
MOTTA, ILARIA
A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19
2015-01-01 Motta, Ilaria; Calcagno, Andrea; Baietto, Lorena; D'Avolio, Antonio; De Rosa, Francesco Giuseppe; Bonora, Stefano
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs
2015-01-01 Baietto, Lorena; Calcagno, Andrea; Motta, Ilaria; Baruffi, Katia; Poretti, Viviana; Di Perri, Giovanni; Bonora, Stefano; D'Avolio, Antonio
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.
2014-01-01 De Rosa FG;Motta I;Corcione S;Cattel F;Di Perri G;D'Avolio A
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia
2017-01-01 Motta, Ilaria; Allice, Tiziano; Romito, Alessandra; Ferrara, Micol; Ecclesia, Sara; Imperiale, Daniele; Ghisetti, Valeria; Di Perri, Giovanni; Bonora, Stefano; Calcagno, Andrea
Dried Plasma/Blood Spots for Monitoring Antiretroviral Treatment Efficacy and Pharmacokinetics: a Cross-sectional Study in Rural Burundi.
2015-01-01 Calcagno A;Motta I;Milia M;Rostagno R;Simiele M;Libanore V;Fontana S;D'Avolio A;Ghisetti V;Di Perri G;Bonora S
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity
2021-01-01 Mattia Trunfio, Elena Salvador, Alberto Gaviraghi, Sabrina Audagnotto, Letizia Marinaro, Ilaria Motta, Riccardo Casciaro, Valeria Ghisetti, Carmen Fava, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno
Economic impact of antifungal treatment in IFD by Candida species: Anidulafungin administration as a cost-effective alternative for critical care patients
2015-01-01 Cattel, F; Ancona, F.; Chiumente, M.; Miliacca, A.; Motta, I.; De Rosa, F.G.
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients.
2015-01-01 Baietto L;D'Avolio A;Cusato J;Pace S;Calcagno A;Motta I;Corcione S;Di Perri G;De Rosa FG
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients
2016-01-01 Calcagno, Andrea; Simiele, Marco; Motta, Ilaria; Mornese Pinna, Simone; Bertucci, Roberto; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
2013-01-01 De Rosa, Francesco G; Motta, Ilaria; Audisio, Ernesta; Frairia, Chiara; Busca, Alessandro; Di Perri, Giovanni; Marmont, Filippo
Erratum: A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 patient
2016-01-01 Motta, Ilaria; Calcagno, Andrea; Baietto, Lorena; D'Avolio, Antonio; De Rosa, Francesco Giuseppe; Bonora, Stefano
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study
2016-01-01 Fatiguso, Giovanna; Allegra, Sarah; Calcagno, Andrea; Baietto, Lorena; Motta, Ilaria; Favata, Fabio; Cusato, Jessica; Bonora, Stefano; Di Perri, Giovanni; D'Avolio, Antonio
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis.
2014-01-01 Calcagno A;Cusato J;Simiele M;Motta I;Audagnotto S;Bracchi M;D'Avolio A;Di Perri G;Bonora S
HIV-1 Very Low Level Viremia is Associated with Virological Failure in HAART-treated Patients
2015-01-01 Calcagno, A; Motta, I; Ghisetti, V; Lo Re, S; Allice, T; Marinaro, L; Milia, Mg; Tettoni, Mc; Trentini, L; Orofino, G; Salassa, B; Di Perri, G; Bonora, S1.
Level of HIV Viremia Below 50 copies/ml Predicts Virologic Rebound in HAART-treated Patients
2013-01-01 Calcagno A; Ghisetti V; Lo Re S; Motta I; Allice T; Marinaro L; Tettoni MC; Trentini L; Bramato C; Orofino G; Bonasso M; Salassa B; Di Perri G; Bonora S
Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines?
2019-01-01 Sekaggya-Wiltshire C.; Chirehwa M.; Musaazi J.; Von Braun A.; Buzibye A.; Muller D.; Gutteck U.; Motta I.; Calcagno A.; Fehr J.S.; Kambugu A.; Castelnuovo B.; Lamorde M.; Denti P.
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting.
2014-01-01 Corcione S;Motta I;Fossati L;Campanile F;Stefani S;Cavallo R;Di Perri G;Ranieri VM;De Rosa FG
Personalization Of Antitubercular Treatment: Evaluation Of Pharmacological Determinants Of Treatment Response
2018-05-27
Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?
2017-01-01 Motta, Ilaria; Calcagno, Andrea; Bonora, Stefano
Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs
2017-01-01 Motta, Ilaria; Calcagno, Andrea; Baietto, Lorena; Bigliano, Paolo; Costa, Cecilia; Baruffi, Katia; Fatiguso, Giovanna; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 | 2015 | Motta, Ilaria; Calcagno, Andrea; Baietto, Lorena; D'Avolio, Antonio; De Rosa, Francesco Giuseppe; Bonora, Stefano | |
| A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs | 2015 | Baietto, Lorena; Calcagno, Andrea; Motta, Ilaria; Baruffi, Katia; Poretti, Viviana; Di Perri, Giovanni; Bonora, Stefano; D'Avolio, Antonio | |
| Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. | 2014 | De Rosa FG;Motta I;Corcione S;Cattel F;Di Perri G;D'Avolio A | |
| Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia | 2017 | Motta, Ilaria; Allice, Tiziano; Romito, Alessandra; Ferrara, Micol; Ecclesia, Sara; Imperiale, Daniele; Ghisetti, Valeria; Di Perri, Giovanni; Bonora, Stefano; Calcagno, Andrea | |
| Dried Plasma/Blood Spots for Monitoring Antiretroviral Treatment Efficacy and Pharmacokinetics: a Cross-sectional Study in Rural Burundi. | 2015 | Calcagno A;Motta I;Milia M;Rostagno R;Simiele M;Libanore V;Fontana S;D'Avolio A;Ghisetti V;Di Perri G;Bonora S | |
| Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity | 2021 | Mattia Trunfio, Elena Salvador, Alberto Gaviraghi, Sabrina Audagnotto, Letizia Marinaro, Ilaria Motta, Riccardo Casciaro, Valeria Ghisetti, Carmen Fava, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno | |
| Economic impact of antifungal treatment in IFD by Candida species: Anidulafungin administration as a cost-effective alternative for critical care patients | 2015 | Cattel, F; Ancona, F.; Chiumente, M.; Miliacca, A.; Motta, I.; De Rosa, F.G. | |
| Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. | 2015 | Baietto L;D'Avolio A;Cusato J;Pace S;Calcagno A;Motta I;Corcione S;Di Perri G;De Rosa FG | |
| Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients | 2016 | Calcagno, Andrea; Simiele, Marco; Motta, Ilaria; Mornese Pinna, Simone; Bertucci, Roberto; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano | |
| Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis | 2013 | De Rosa, Francesco G; Motta, Ilaria; Audisio, Ernesta; Frairia, Chiara; Busca, Alessandro; Di Perri, Giovanni; Marmont, Filippo | |
| Erratum: A probable drug-to-drug interaction between voriconazole and haloperidol in a slow metabolizer of CYP2C19 patient | 2016 | Motta, Ilaria; Calcagno, Andrea; Baietto, Lorena; D'Avolio, Antonio; De Rosa, Francesco Giuseppe; Bonora, Stefano | |
| Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study | 2016 | Fatiguso, Giovanna; Allegra, Sarah; Calcagno, Andrea; Baietto, Lorena; Motta, Ilaria; Favata, Fabio; Cusato, Jessica; Bonora, Stefano; Di Perri, Giovanni; D'Avolio, Antonio | |
| High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis. | 2014 | Calcagno A;Cusato J;Simiele M;Motta I;Audagnotto S;Bracchi M;D'Avolio A;Di Perri G;Bonora S | |
| HIV-1 Very Low Level Viremia is Associated with Virological Failure in HAART-treated Patients | 2015 | Calcagno, A; Motta, I; Ghisetti, V; Lo Re, S; Allice, T; Marinaro, L; Milia, Mg; Tettoni, Mc; Trentini, L; Orofino, G; Salassa, B; Di Perri, G; Bonora, S1. | |
| Level of HIV Viremia Below 50 copies/ml Predicts Virologic Rebound in HAART-treated Patients | 2013 | Calcagno A; Ghisetti V; Lo Re S; Motta I; Allice T; Marinaro L; Tettoni MC; Trentini L; Bramato C; Orofino G; Bonasso M; Salassa B; Di Perri G; Bonora S | |
| Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines? | 2019 | Sekaggya-Wiltshire C.; Chirehwa M.; Musaazi J.; Von Braun A.; Buzibye A.; Muller D.; Gutteck U.; Motta I.; Calcagno A.; Fehr J.S.; Kambugu A.; Castelnuovo B.; Lamorde M.; Denti P. | |
| Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. | 2014 | Corcione S;Motta I;Fossati L;Campanile F;Stefani S;Cavallo R;Di Perri G;Ranieri VM;De Rosa FG | |
| Personalization Of Antitubercular Treatment: Evaluation Of Pharmacological Determinants Of Treatment Response | 2018 | - | |
| Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization? | 2017 | Motta, Ilaria; Calcagno, Andrea; Bonora, Stefano | |
| Pharmacokinetics of first-line antitubercular drugs in plasma and PBMCs | 2017 | Motta, Ilaria; Calcagno, Andrea; Baietto, Lorena; Bigliano, Paolo; Costa, Cecilia; Baruffi, Katia; Fatiguso, Giovanna; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano |